-
Boehringer Ingelheim and OSE Immunotherapeutics Ink $1.4B Deal
- Source: Pharmalive
- 449
- April 10, 2018
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
